Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1

Status

Completed 5Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 7Gynecologic 6Genitourinary 6Gastrointestinal 6Other hematologic neoplasm 3Head & Neck 3Tumor-Agnostic 2CNS 2Breast 2Plasma cell 1Other 1Dermatologic 1Classical hematology 1

Conditions

Stomach Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Colorectal Neoplasms 2Pancreatic Cyst 1

Interventions

Fluorouracil 286Oxaliplatin 274Gemcitabine 222Capecitabine 221Leucovorin 219Bevacizumab 200Irinotecan 170pembrolizumab 141Cisplatin 132Cetuximab 111Radiotherapy 109Sorafenib 75Nivolumab 75130-nm albumin-bound paclitaxel 64Paclitaxel 63Albumin-Bound Paclitaxel 63Docetaxel 61Erlotinib Hydrochloride 57Panitumumab 56Radiosurgery 47Folfox protocol 46regorafenib 45Sunitinib 40Radiation 39Magnetic Resonance Spectroscopy 38durvalumab 33Surgical Procedures, Operative 33Ramucirumab 33Trastuzumab 32Cyclophosphamide 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Saline Solution × Gastrointestinal × Clear all
NCT02134925 2026-05-28

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

National Cancer Institute (NCI)

Phase 2 Active not recruiting
110 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT03221426 2026-03-09

KEYNOTE-585

Merck Sharp & Dohme LLC

Phase 3 Completed
1,007 enrolled 25 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT04882241 2026-03-06

KEYNOTE-585

Merck Sharp & Dohme LLC

Phase 3 Completed
120 enrolled 17 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT05124704 2025-01-09

Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia

Zhejiang Cancer Hospital

Phase NA Completed
60 enrolled 9 charts
Gastrointestinal

Stomach Neoplasms

NCT00614393 2018-08-08

Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)

Merck Sharp & Dohme LLC

Phase 2 Completed
558 enrolled 17 charts
Gastrointestinal

Colorectal Neoplasms

NCT01475331 2018-03-20

The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Milton S. Hershey Medical Center

Phase 2 Completed
46 enrolled 8 charts
Gastrointestinal

Pancreatic Cyst

Data powered by HemOnc (CC BY 4.0) Colophon âš¡